Yap Desiree, Liang Xinyu, Garland Suzanne M, Hartley Stefanie, Gorelik Alexandra, Ogilvie Gina, Tan Jeffrey, Wrede C David H, Jayasinghe Yasmin
Dysplasia Unit, Royal Women's Hospital, Parkville, Victoria, Australia.
Medicine, Dentistry and Health Sciences, University of Melbourne, Carlton, Victoria, Australia.
J Clin Virol. 2016 Mar;76 Suppl 1:S81-S87. doi: 10.1016/j.jcv.2015.11.018. Epub 2015 Nov 19.
Australian guidelines for cervical cancer screening are being revised under the "renewal program". Physicians' willingness to accept these changes will play a pivotal role in its success.
To understand the willingness and acceptance of, as well as barriers and facilitators for Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) affiliates to screening using human papillomavirus (HPV) testing, starting at 25 years of age, every 5 years.
An electronic survey of RANZCOG affiliates was undertaken April-June 2014, while renew was announced April 28th 2014. Responses used a 7 point Likert scale, which was dichotomized as ≤4, indicating 'unwilling' and >4, indicating 'willing' to adopt revised practices.
Response rate was 22% (n=956): 60% were obstetricians and gynaecologists (OG); 27% general practitioner diplomates; 13% OG trainees. Overall, 60% (n=526/874) were willing to revise their screening practice. This correlated with awareness of new guidelines (p=<0.001). Fifty percent (n=438/869) of respondents were concerned about delaying to 25 years, and 48% (n=421/869) concerned cervical cancers would be missed. Reasons respondents gave for wishing to continue screening from 18 years contrary to guidelines included: women not being vaccinated (65.6%), immunosuppressed women (92.2%) and women who had been victims of childhood sexual assault (73.9%).
The majority of RANZCOG affiliates were willing to change screening practice however, a number of barriers to delaying onset of screening age to age 25 years were reported. Effective change management strategies will need to be implemented to address the concerns raised to ensure best practice for cervical screening.
澳大利亚宫颈癌筛查指南正在“更新计划”下进行修订。医生对这些变化的接受意愿将对其成功起到关键作用。
了解澳大利亚和新西兰皇家妇产科医师学院(RANZCOG)成员对于从25岁开始每5年进行一次人乳头瘤病毒(HPV)检测筛查的意愿、接受程度以及障碍和促进因素。
在2014年4月至6月期间对RANZCOG成员进行了一项电子调查,而更新于2014年4月28日宣布。回答采用7分李克特量表,分为≤4分表示“不愿意”,>4分表示“愿意”采用修订后的做法。
回复率为22%(n = 956):60%为妇产科医生(OG);27%为全科医生文凭持有者;13%为OG实习生。总体而言,60%(n = 526/874)愿意修订其筛查做法。这与对新指南的知晓程度相关(p = <0.001)。50%(n = 438/869)的受访者担心推迟到25岁,48%(n = 421/869)担心会漏诊宫颈癌。受访者给出的希望违背指南从18岁开始继续筛查的原因包括:女性未接种疫苗(65.6%)、免疫抑制女性(92.2%)以及童年遭受性侵犯的女性(73.9%)。
大多数RANZCOG成员愿意改变筛查做法,然而,报告了一些将筛查起始年龄推迟到25岁的障碍。需要实施有效的变革管理策略来解决所提出的担忧,以确保宫颈癌筛查的最佳实践。